Cronos Group News

Cronos Group Analyst Ratings

BenzingaApr 8 05:47 ET

Analysts Offer Insights on Healthcare Companies: Precigen (PGEN), Cronos Group (CRON) and Marinus (MRNS)

TipRanksMar 26 08:10 ET

Jefferies Sticks to Its Hold Rating for Cronos Group (CRON)

TipRanksJan 7 07:38 ET

Jefferies Keeps Their Hold Rating on Cronos Group (CRON)

TipRanksJan 3 07:48 ET

Jefferies Sticks to Its Hold Rating for Cronos Group (CRON)

TipRanksDec 29, 2023 07:44 ET

B of A Securities Maintains Underperform on Cronos Group, Raises Price Target to $2

BenzingaDec 28, 2023 05:37 ET

Cronos Group Analyst Ratings

BenzingaDec 28, 2023 05:30 ET

Cronos Group Sell Rating Affirmed Amid Modest Sales Forecasts and Competitive Challenges

TipRanksDec 28, 2023 05:26 ET

Cronos Group (CRON) Gets a Hold From Jefferies

TipRanksDec 26, 2023 07:46 ET

Jefferies Keeps Their Hold Rating on Cronos Group (CRON)

TipRanksDec 24, 2023 07:58 ET

Positive Market Outlook and Financial Health: A Buy Rating for Cronos Group

TipRanksNov 9, 2023 13:22 ET

Sell Rating on Cronos Group: Uncertainty in Profitability and Regulatory Changes Overshadowing Robust Sales Performance

TipRanksNov 8, 2023 21:49 ET

Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), Harmony Biosciences Holdings (HRMY) and Cronos Group (CRON)

TipRanksNov 1, 2023 05:32 ET

Tilray a Top Pick in Seeking Alpha's Quant Ratings Despite Short Interest

Seeking AlphaSep 20, 2023 10:41 ET

Roth MKM Reiterates Buy on Cronos Group, Maintains C$5 Price Target

BenzingaSep 1, 2023 11:09 ET

Cronos Group (CRON) Receives a Buy From Roth MKM

TipRanksSep 1, 2023 05:45 ET

Bank of America Securities Keeps Their Sell Rating on Cronos Group (CRON)

TipRanksAug 9, 2023 05:05 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Acumen Pharmaceuticals (ABOS) and Cronos Group (CRON)

TipRanksAug 1, 2023 06:10 ET

Analysts Offer Insights on Healthcare Companies: Cronos Group (CRON), Travere Therapeutics (TVTX) and Ascendis Pharma (ASND)

TipRanksJun 1, 2023 05:40 ET

Barclays Maintains Equal-Weight on Cronos Group, Lowers Price Target to $3

BenzingaMay 15, 2023 07:03 ET